MESO

Mesoblast

• TipRanks·2d ago

  Mesoblast Limited (MEOBF) Receives a Buy from Bell Potter

• TipRanks·09/25 15:40

  Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS) and Mesoblast (MESO)

• Benzinga·09/24 11:06

  Mesoblast Receives FDA Approval To Implement A New Potency Assay, T-Cell Proliferation Inhibition Bioassay, For Release And Stability Monitoring Of All New Commercial Product Lots Of Its Mesenchymal Stromal Cell Product Ryoncil

• Seeking Alpha·09/20 18:57

  FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

• TipRanks·09/04 12:10

  Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Mesoblast (MESO)

• TipRanks·08/31 12:16

  Jefferies Keeps Their Buy Rating on Mesoblast Limited (MEOBF)

• TipRanks·08/31 06:07

  Post-Approval Safety Risks Threaten Mesoblast’s Ryoncil Commercialization in Fragile Pediatric SR-aGVHD Market

• TipRanks·08/30 00:11

  Mesoblast Earnings Call: RYONCIL Fuels Growth Story

• Dow Jones·08/27 21:30

  *Mesoblast Price Target Cut 3.3% to A$2.90/Share by Jefferies

• Benzinga·08/27 17:25

  Piper Sandler Reiterates Overweight on Mesoblast, Raises Price Target to $39

• Benzinga·08/27 13:00

  Mesoblast FY EPS $(0.04) Misses $0.01 Estimate, Sales $120.250M Beat $66.000M Estimate

• TipRanks·08/27 10:45

  Mesoblast price target raised to $39 from $35 at Piper Sandler

• Benzinga·08/26 23:25

  Full Transcript: Mesoblast FY 2026 Earnings Call

• Seeking Alpha·08/26 14:00

  Here are the major earnings after the close Wednesday

• TipRanks·08/26 12:45

  Largest borrow rate increases among liquid names